The global cell culture protein surface coating market size is expected to reach around USD 1.7 billion by 2026.
Increasing focus on stem cell research and development is the most substantial factor that drives the market growth during the forecast period. Stem cell therapy is the most promising method to treat severe medical conditions such as cardiovascular disease, brain disease, cell deficiency therapy, and blood disease. Thus, the biotechnology companies and research laboratories are adopting innovative protein surface coating products for the development of stem cells.
Rising demand for biopharmaceutical products including antibodies, vaccines, proteins, and drugs is another major factor driving the growth of the cell culture protein surface coating market. The production of biopharmaceutical products such as monoclonal antibodies and recombinant proteins is carried out by using cell culture technique. The protein surface coating provides improved adhesion and proliferation of cells in vitro. Thus, the demand of cell culture protein surface coating is growing at a high rate, which is estimated to drive the growth of this sector.
The report segments the global cell culture protein surface coating market based on coating type, protein source, and region. Based on coating type, it is bifurcated into precoating and self-coating. Pre-coating is further segmented into multiwall/microwell plates, flasks, petri dishes, slides, and cover slips. By protein source, it is classified into animal-derived, human-derived, synthetic, and plant-derived protein. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Key players operating in the market include Reckitt Benckiser Group plc, Johnson & Johnson, GlaxoSmithKline plc, Novartis AG, Bayer AG, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co.
Key Benefits
Segmentation:
By Coating Type
By Protein Source
By Region
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 CELL CULTURE PROTEIN SURFACE COATING MARKET, BY COATING TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. PRECOATING
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. MULTIWALL/MICROWELL PLATES
4.3.1. Market size and forecast
4.4. FLASKS
4.4.1. Market size and forecast
4.5. PETRI DISHES
4.5.1. Market size and forecast
4.6. SLIDES
4.6.1. Market size and forecast
4.7. COVER SLIPS
4.7.1. Market size and forecast
4.8. SELF-COATING
4.8.1. Key market trends
4.8.2. Growth factors and opportunities
4.8.3. Market size and forecast
CHAPTER 5 CELL CULTURE PROTEIN SURFACE COATING MARKET, BY PROTEIN SOURCE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ANIMAL-DERIVED PROTEIN
5.2.1. Market size and forecast
5.3. HUMAN-DERIVED PROTEIN
5.3.1. Market size and forecast
5.4. SYNTHETIC PROTEIN
5.4.1. Market size and forecast
5.5. PLANT-DERIVED PROTEIN
5.5.1. Market size and forecast
CHAPTER 6 CELL CULTURE PROTEIN SURFACE COATING MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America cell culture protein surface coating market by coating type
6.2.5. North America cell culture protein surface coating market by protein source
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe cell culture protein surface coating market by coating type
6.3.5. Europe cell culture protein surface coating market by protein source
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific cell culture protein surface coating market by coating type
6.4.5. Asia-Pacific cell culture protein surface coating market by protein source
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast
6.5.4. LAMEA cell culture protein surface coating market by coating type
6.5.5. LAMEA cell culture protein surface coating market by protein source
CHAPTER 7 COMPANY PROFILES
7.1. RECKITT BENCKISER GROUP PLC
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. JOHNSON & JOHNSON
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. GLAXOSMITHKLINE PLC
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. NOVARTIS AG
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. BAYER AG
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. ASTRAZENECA PLC
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. SUN PHARMACEUTICAL INDUSTRIES LTD.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. PFIZER INC.
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. PRESTIGE BRANDS HOLDINGS, INC.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. PROCTER & GAMBLE CO.
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers